☆ 4.6 Article

BIRC5 facilitates cisplatin-chemoresistance in a m6A-dependent manner in ovarian cancer

CANCER MEDICINE (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Biochemistry & Molecular Biology

The Role of NQO1 in Ovarian Cancer

Giovanni Tossetta et al.

Summary: Ovarian cancer is a dangerous gynecologic malignancy with high fatality rate. Oxidative stress and NQO1 play important roles in the occurrence and progression of ovarian cancer. This review summarizes the evidence from literature regarding the effect of NQO1 on ovarian cancer.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

添加到收藏夹

Article Oncology

The tumor suppressor role and ceRNA network of miR-1294 in cancer

Yunan Mao et al.

Summary: miRNAs are important regulators of gene expression, and miR-1294 has been found to be significantly down-regulated in 15 cancers and regulated by 21 upstream regulators. It affects cancer cell proliferation, migration, invasion, and apoptosis, and its target genes are involved in important signaling pathways. Low expression of miR-1294 is associated with drug resistance and poorer prognosis in several types of cancer, emphasizing its clinical significance as a tumor suppressor.

ONCOLOGY RESEARCH (2023)

添加到收藏夹

Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

添加到收藏夹

Article Oncology

BIRC5 regulates inflammatory tumor microenvironment-induced aggravation of penile cancer development in vitro and in vivo

Yang Zhao et al.

Summary: In this study, the overexpression of BIRC5 in penile cancer was explored, and its role in the progression of the disease was investigated. Silencing of BIRC5 inhibited the proliferation, migration, and invasion of penile cancer cells and improved tumor growth and mouse survival. Furthermore, interferon-gamma was found to aggravate penile cancer progression, while the silencing of BIRC5 reversed these effects, suggesting BIRC5 as a potential diagnostic and therapeutic target for penile cancer.

BMC CANCER (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N6-methyladenosine modification of PD-L1 mRNA in breast cancer

Weijun Wan et al.

Summary: The study found that METTL3 can post-transcriptionally upregulate PD-L1 expression in an m(6)A-IGF2BP3-dependent manner to promote stabilization of PD-L1 mRNA. This may have important implications for new and efficient therapeutic strategies in tumor immunotherapy.

MOLECULAR CANCER (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Fusobacterium nucleatum reduces METTL3-mediated m6A modification and contributes to colorectal cancer metastasis

Shujie Chen et al.

Summary: The study reveals that Fusobacterium nucleatum contributes to colorectal cancer (CRC) progression by reducing global m(6)A modifications through a YAP/FOXD3/METTL3/KIF26B axis. Fusobacterium nucleatum is closely associated with the development of CRC.

NATURE COMMUNICATIONS (2022)

添加到收藏夹

Review Oncology

The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer

Nidhi Jyotsana et al.

Summary: SLC7A11 is an antiporter that mediates the exchange of extracellular cystine for intracellular glutamate. It plays diverse functional roles in maintaining redox homeostasis and immune system function, and is associated with the development and drug resistance of diseases such as cancer. In this review, the focus is on discussing its molecular functions and therapeutic strategies in gastrointestinal cancers.

FRONTIERS IN ONCOLOGY (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Role of NRF2 in Ovarian Cancer

Giovanni Tossetta et al.

Summary: This review summarizes the role of NRF2 in ovarian cancer, focusing on its function in drug resistance, natural and synthetic modulators of NRF2, and its protective function in normal ovarian preservation.

ANTIOXIDANTS (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

METTL3 Inhibits Antitumor Immunity by Targeting m6A-BHLHE41-CXCL1/CXCR2 Axis to Promote Colorectal Cancer

Huarong Chen et al.

Summary: This study identifies METTL3 as a potential therapeutic target for CRC immunotherapy. Silencing or inhibiting METTL3 reduces MDSC accumulation, sustains activation and proliferation of CD4(+) and CD8(+) T cells, and ultimately suppresses CRC development. Inhibition of METTL3 plus anti-PD1 treatment shows promising antitumor efficacy against CRC.

GASTROENTEROLOGY (2022)

添加到收藏夹

Article Medicine, Research & Experimental

Tumor-suppressive MEG3 induces microRNA-493-5p expression to reduce arabinocytosine chemoresistance of acute myeloid leukemia cells by downregulating the METTL3/MYC axis

Airong Wang et al.

Summary: This study found that MEG3 can increase the expression of miR-493-5p and suppress the METTL3/MYC axis through MYC m6A methylation, thereby enhancing the chemosensitivity of AML cells.

JOURNAL OF TRANSLATIONAL MEDICINE (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

Natural and synthetic compounds in Ovarian Cancer: A focus on NRF2/KEAP1 pathway

Giovanni Tossetta et al.

Summary: This review discusses the role of natural and synthetic compounds in modulating the NRF2/KEAP1 pathway in in vitro models of ovarian cancer and how these compounds can regulate chemotherapy response.

PHARMACOLOGICAL RESEARCH (2022)

添加到收藏夹

Article Cell Biology

Inhibition of USP1 enhances anticancer drugs-induced cancer cell death through downregulation of survivin and miR-216a-5p-mediated upregulation of DR5

Seon Min Woo et al.

Summary: This study found that USP1 is highly expressed in tumor tissues and is associated with poor prognosis in RCC. Mechanistically, USP1 enhances survivin stabilization by removing ubiquitin and upregulates DR5 expression by decreasing miR-216a-5p expression at the post-transcriptional level. Inhibition of USP1 sensitizes cancer cells and reduces tumor size.

CELL DEATH & DISEASE (2022)

添加到收藏夹

Article Multidisciplinary Sciences

METTL3 acetylation impedes cancer metastasis via fine-tuning its nuclear and cytosolic functions

Yuanpei Li et al.

Summary: In this study, the authors identify an acetylation-mediated regulation of METTL3 subcellular localization and its impact on breast cancer metastasis. They also uncover an IL-6-dependent positive feedback axis that facilitates nuclear METTL3 functions, promoting metastasis. Additionally, the study shows that aspirin treatment and SIRT1 inhibition can counterbalance the acetylation-dependent regulation of METTL3 localization and impair m(6)A methylation, leading to reduced lung metastasis.

NATURE COMMUNICATIONS (2022)

添加到收藏夹

Article Cell Biology

METTL3 promotes m6A hypermethylation of RBM14 via YTHDF1 leading to the progression of hepatocellular carcinoma

Jingyao Hu et al.

Summary: This study investigated the role of METTL3 in HCC progression and its impact on KC polarization, revealing that METTL3 depletion can inhibit M2 polarization of KCs and reverse the malignant phenotype of HCC cells by regulating RBM14 expression via YTHDF1-dependent m6A modification.

HUMAN CELL (2022)

添加到收藏夹

Article Oncology

The Prognostic and Therapeutic Implications of the Chemoresistance Gene BIRC5 in Triple-Negative Breast Cancer

Getinet M. Adinew et al.

Summary: This study identified the potential of the chemoresistance gene BIRC5 as a prognostic biomarker and a therapeutic target in TNBC patients. The findings shed light on the role of BIRC5 in chemotherapy-induced resistance of TNBC, suggesting its potential as a promising prognostic biomarker and therapeutic target.

CANCERS (2022)

添加到收藏夹

Article Oncology

Ovarian Cancer, Version 2.2020

Deborah K. Armstrong et al.

Summary: Epithelial ovarian cancer is a leading cause of gynecologic cancer death in the United States. The NCCN Guidelines discuss various ovarian cancers, focusing on primary treatment aspects and including recommendations for both common and rare subtypes.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)

添加到收藏夹

Review Oncology

Research progress concerning m6A methylation and cancer

Yang Zhou et al.

Summary: N6-methyladenosine (m(6)A) methylation is an important modification on RNA molecules, playing a key role in RNA metabolism across various stages of the RNA life cycle. Recent studies have shown that m(6)A modification is closely associated with the occurrence and development of tumors.

ONCOLOGY LETTERS (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Suppression of mitochondrial ROS by prohibitin drives glioblastoma progression and therapeutic resistance

Haohao Huang et al.

Summary: Prohibitin regulates mitochondrial ROS production by stabilizing the peroxidase PRDX3, contributing to radiotherapy resistance in glioma stem-like cells.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Oncology

Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving

De-Ying Wang et al.

CANCER RESEARCH AND TREATMENT (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy

Yuanjun Lu et al.

MOLECULAR CANCER (2020)

添加到收藏夹

Article Cell Biology

Targeting UDP-glucose dehydrogenase inhibits ovarian cancer growth and metastasis

Li-Hsun Lin et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)

添加到收藏夹

Article Oncology

BIRC5 is a target for molecular imaging and detection of human pancreatic cancer

Shi-He Liu et al.

CANCER LETTERS (2019)

添加到收藏夹

Review Oncology

Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study?

Fengzhi Li et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

添加到收藏夹

Article Oncology

m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis

Dan Jin et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)

添加到收藏夹

Article Medicine, Research & Experimental

LDR reverses DDP resistance in ovarian cancer cells by affecting ERCC-1, Bcl-2, Survivin and Caspase-3 expressions

Xingyan Ju et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

添加到收藏夹

Review Cell Biology

Dynamic transcriptomic m6A decoration: writers, erasers, readers and functions in RNA metabolism

Ying Yang et al.

CELL RESEARCH (2018)

添加到收藏夹

Review Biochemistry & Molecular Biology

Survivin-Based Treatment Strategies for Squamous Cell Carcinoma

Andrea Santarelli et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

添加到收藏夹

Review Biochemistry & Molecular Biology

Aberrant Regulation of mRNA m6A Modification in Cancer Development

Junyun Luo et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

添加到收藏夹

Article Oncology

miR-203 inhibits ovarian tumor metastasis by targeting BIRC5 and attenuating the TGFβ pathway

Baojin Wang et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)

添加到收藏夹

Review Genetics & Heredity

Molecular mechanisms of DNA damage recognition for mammalian nucleotide excision repair

Kaoru Sugasawa

DNA REPAIR (2016)

添加到收藏夹

Review Oncology

The role of DNA repair pathways in cisplatin resistant lung cancer

Shane O'Grady et al.

CANCER TREATMENT REVIEWS (2014)

添加到收藏夹

Article Biochemistry & Molecular Biology

Transcriptional regulation of the survivin gene

Romain Boidot et al.

MOLECULAR BIOLOGY REPORTS (2014)

添加到收藏夹

Review Cell Biology

The dynamic epitranscriptome: N6-methyladenosine and gene expression control

Kate D. Meyer et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.